Form 4 for HLF HERBALIFE LTD.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0000950170-25-027131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-25 | 2025-02-25 | HLF | Wang Henry C | CLO | F - Tax | $8.29 | -2,527 | 159.5K | -2% | -$20.9K |
| D | 2025-02-25 | 2025-02-21 | HLF | Wang Henry C | CLO | A - Grant | $0.00 | +77.4K | 77.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | F | D | 2,527 | $8.29 | 159,517 | D | — | — | (F1) Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022. |
| 2 | Derivative | Stock Appreciation Rights | 2025-02-21 | A | A | 77,433 | $0.00 | 77,433 | D | $8.31 · — to 2035-02-21 | 77,433 Common Stock | (F2) Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 21, 2026, February 21, 2027, and February 21, 2028, subject to continued service through such date. |